Clinical trial
A Phase II Study of Paclitaxel, UFT, and Leucovorin in Patients With Metastatic…
NCT00037089 · Edelman, Martin, M.D., Other · Unknown status
Key facts
| NCT number | NCT00037089 |
|---|---|
| Title | A Phase II Study of Paclitaxel, UFT, and Leucovorin in Patients With Metastatic Esophageal Cancer |
| Lead sponsor | Edelman, Martin, M.D., Other |
| Collaborators | Bristol-Myers Squibb Industry |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Esophageal Neoplasm |
| Intervention type | Drug |
| Interventions | UFT (Tegafur/Uracil) |
| First posted | May 15, 2002 |
| Last update posted | Jun 24, 2005 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: